| dbp:description
|
- Open label, non-randomised, dose escalation. (en)
- Randomized, double-blind, placebo-controlled. (en)
- Randomized, observer-blind, placebo-controlled. (en)
- Randomized, observer-blinded, placebo-controlled. (en)
- Randomized, placebo-controlled, multi-center. (en)
- Randomized, Two-armed, Double-blind, Placebo controlled (en)
- Double-blind, dose-ranging, randomised, placebo-controlled. (en)
- First-In-Human, Open-label, Single Ascending Dose and Multidose. (en)
|
| dbp:participants
|
- 18 (xsd:integer)
- 24 (xsd:integer)
- 40 (xsd:integer)
- 150 (xsd:integer)
- 168 (xsd:integer)
- 280 (xsd:integer)
- 423 (xsd:integer)
- 16876 (xsd:integer)
- * 21,206,612 people aged 12+ have received one dose of COVID-19 vaccine
* 20,806,810 people aged 12+ have been fully vaccinated with two doses of vaccine
* 14,097,289 people aged 12+ have been booster given with three doses of vaccine (en)
|
| dbp:whenwhere
|
- Aug 20202021, Australia (en)
- Aug 2021–Jan 2022, Australia (en)
- AugSep 2021, Iran (en)
- Feb 2021Jun 2022, Australia, Thailand (en)
- Jun Dec 2021, Australia (en)
- Jun 2021–2022, Australia (en)
- Mar Dec 2022, Australia (en)
- Nov 2020 Feb 2022, Australia (en)
|
